Zimmer Biomet Holdings Inc (ZBH) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.

Total Revenue Chart for Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc (ZBH) revenue for FY2025 was USD 8.2B, a 7.2% change from FY2024. Zimmer Biomet Holdings Inc's revenue grew from USD 861.0M in 1998 to USD 8.2B in 2025 (856.0% over 27 years). Earnings per share grew from USD 0.91 in 2000 to USD 3.55 in 2025 (290.3%). Revenue compound annual growth rate: 5-year CAGR of 6.1%, 10-year CAGR of 3.2%, 20-year CAGR of 4.7%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.